What to Do After Progression on Immunotherapy and for Non-Driver NSCLC – OncLive
OncLive |
What to Do After Progression on Immunotherapy and for Non-Driver NSCLC
OncLive Panelists: Mark A. Socinski, MD, Florida Hospital Cancer Institute; Tracey L. Evans, MD, University of Pennsylvania; Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center; Vali A. Papadimitrakopoulou, MD, The University of Texas MD Anderson … |
